176 related articles for article (PubMed ID: 15737557)
21. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
[TBL] [Abstract][Full Text] [Related]
22. Melanoma in children and the use of sentinel lymph node biopsy.
Bütter A; Hui T; Chapdelaine J; Beaunoyer M; Flageole H; Bouchard S
J Pediatr Surg; 2005 May; 40(5):797-800. PubMed ID: 15937817
[TBL] [Abstract][Full Text] [Related]
23. In transit/local recurrences in melanoma patients after sentinel node biopsy and therapeutic lymph node dissection.
Rutkowski P; Nowecki ZI; Zurawski Z; Dziewirski W; Nasierowska-Guttmejer A; Switaj T; Ruka W
Eur J Cancer; 2006 Jan; 42(2):159-64. PubMed ID: 16324835
[TBL] [Abstract][Full Text] [Related]
24. Prognostic heterogeneity after the excision of lymph node metastases in patients with cutaneous melanoma.
Pilko G; Besic N; Zgajnar J; Hocevar M
Surg Oncol; 2011 Mar; 20(1):26-34. PubMed ID: 19900803
[TBL] [Abstract][Full Text] [Related]
25. Metastatic pattern and survival in disseminated conjunctival melanoma: implications for sentinel lymph node biopsy.
Tuomaala S; Kivelä T
Ophthalmology; 2004 Apr; 111(4):816-21. PubMed ID: 15051218
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant postoperative radiotherapy to the cervical lymph nodes in cutaneous melanoma: is there any benefit for high-risk patients?
Moncrieff MD; Martin R; O'Brien CJ; Shannon KF; Clark JR; Gao K; McCarthy WM; Thompson JF
Ann Surg Oncol; 2008 Nov; 15(11):3022-7. PubMed ID: 18958539
[TBL] [Abstract][Full Text] [Related]
27. Sentinel lymph node biopsy in cutaneous melanoma: outcome after 5-years follow-up.
Cuchet E; Pinel N; Corcella D; Vuillez JP; Lebeau J; Moutet F; Colonna M; Leccia MT
Eur J Dermatol; 2007; 17(5):387-91. PubMed ID: 17673381
[TBL] [Abstract][Full Text] [Related]
28. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004.
Berk DR; Johnson DL; Uzieblo A; Kiernan M; Swetter SM
Arch Dermatol; 2005 Aug; 141(8):1016-22. PubMed ID: 16103331
[TBL] [Abstract][Full Text] [Related]
29. Sentinel lymph node biopsy in thin melanoma patients.
Hershko DD; Robb BW; Lowy AM; Ahmad SA; Ramadas GH; Soldano DA; Sussman JJ
J Surg Oncol; 2006 Mar; 93(4):279-85. PubMed ID: 16496355
[TBL] [Abstract][Full Text] [Related]
30. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
[TBL] [Abstract][Full Text] [Related]
31. Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy.
Sabel MS; Griffith KA; Arora A; Shargorodsky J; Blazer DG; Rees R; Wong SL; Cimmino VM; Chang AE
Surgery; 2007 Jun; 141(6):728-35. PubMed ID: 17560249
[TBL] [Abstract][Full Text] [Related]
32. Pathobiology of the sentinel node.
Cochran AJ; Ohsie SJ; Binder SW
Curr Opin Oncol; 2008 Mar; 20(2):190-5. PubMed ID: 18300769
[TBL] [Abstract][Full Text] [Related]
33. Lymphatic mapping and sentinel lymphonodectomy in recurrent cutaneous squamous cell carcinomas.
Cecchi R; Buralli L; de Gaudio C
Eur J Dermatol; 2005; 15(6):478-9. PubMed ID: 16280303
[TBL] [Abstract][Full Text] [Related]
34. Combined-modality therapy for patients with regional nodal metastases from melanoma.
Ballo MT; Ross MI; Cormier JN; Myers JN; Lee JE; Gershenwald JE; Hwu P; Zagars GK
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):106-13. PubMed ID: 16182463
[TBL] [Abstract][Full Text] [Related]
35. Full-thickness grafts procured from skin overlying the sentinel lymph node basin; reconstruction of primary cutaneous malignancy excision defects.
Lewis JM; Zager JS; Yu D; Pelaez D; Riker AI; Dessureault S; Cruse CW; Reintgen DS; Puleo CA; Sondak VK
Ann Surg Oncol; 2008 Jun; 15(6):1733-40. PubMed ID: 18379848
[TBL] [Abstract][Full Text] [Related]
36. Sentinel node identification by scintigraphic methods in cutaneous melanoma.
Dias Moreira R; Altino de Almeida S; Maliska Guimarães CM; Resende JF; Gutfilen B; Barbosa da Fonseca LM
J Exp Clin Cancer Res; 2005 Jun; 24(2):181-5. PubMed ID: 16110749
[TBL] [Abstract][Full Text] [Related]
37. Patterns of recurrence in patients with melanoma after radical lymph node dissection.
Nathansohn N; Schachter J; Gutman H
Arch Surg; 2005 Dec; 140(12):1172-7. PubMed ID: 16365238
[TBL] [Abstract][Full Text] [Related]
38. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma.
Scheri RP; Essner R; Turner RR; Ye X; Morton DL
Ann Surg Oncol; 2007 Oct; 14(10):2861-6. PubMed ID: 17882497
[TBL] [Abstract][Full Text] [Related]
39. Sentinel lymph node micrometastasis may predict non-sentinel involvement in cutaneous melanoma patients.
Glumac N; Hocevar M; Zadnik V; Snoj M
J Surg Oncol; 2008 Jul; 98(1):46-8. PubMed ID: 18452214
[TBL] [Abstract][Full Text] [Related]
40. A sentinel node biopsy does not increase the incidence of in-transit metastasis in patients with primary cutaneous melanoma.
van Poll D; Thompson JF; Colman MH; McKinnon JG; Saw RP; Stretch JR; Scolyer RA; Uren RF
Ann Surg Oncol; 2005 Aug; 12(8):597-608. PubMed ID: 16021534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]